were starved in serum-free medium (SFM) or maintained in serum-containing medium for 24 h and subsequently stimulated or not with 20% FBS to assess RhoA activity. All immunoblots were exposed to a monospecific anti-RhoA antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and the results are representative of two similar 2 independent experiments. Additionally, the Western blots of the parental, MeWoRhoA-V14 and MeWo-RhoA-N19 clones were systematically examined using the same gel and were exposed together using the Odyssey Infra-Red Scanner; therefore, there were no differences in the exposure time between the samples. B) Total and active (GTP bound) RhoA bands were quantified by the Odyssey Infra-Red Scanner Software V3.0 and shown as the RhoA-GTP/Total RhoA rate in bars graph as average +/-standard deviation. 
